Skip to main content
Get the Weekly ESG Brief

Johnson & Johnson

JNJNYSETrackedESG Rated: 2/2 ProvidersMarket Data VerifiedHealth CarePharmaceuticalsMSCI: ASustainalytics: 23.0 · Medium

Coverage
Rated universe Carries an MSCI or Sustainalytics observation.
ESG profile reviewed
Last editorial update to this profile.
Quote
Last verified closeObservation time is shown beside the price.
Methodology
How we rateProvider ratings are shown separately, never blended.

Market overview

USD 259.36

Up+USD 5.57 (+2.19%) Day change

Last verified close · As of · USD · Market data via Massive Stock Widgets

The market is closed. This is the last verified closing quote, not an intraday price.

Open
USD 257.48
Previous close
USD 253.79
Day high
USD 260.77
Day low
USD 256.42
Volume
7,634,901
Market cap
USD 625,031,249,920
Price chart · 1 Year
Johnson & Johnson 1 Year price chartJohnson & Johnson, nyse:JNJ, 1 Year price chart in USD. Start USD 193.72, end USD 253.79, high USD 278.43, low USD 186.00, up.
Period1 YearFirst closeUSD 193.72Last closeUSD 253.79Maximum closeUSD 278.43Minimum closeUSD 186.00Period change+USD 60.07Period percentage change+31.01%Chart as ofOct 19, 2026, 1:30 PM GMT+0000
View Chart Data
Representative chart points — 24 of 251
Date and time Open High Low Close Volume
USD 193.50 USD 194.48 USD 192.33 USD 193.72 8,034,700
USD 186.64 USD 187.83 USD 185.40 USD 186.00 5,049,400
USD 202.98 USD 203.45 USD 200.81 USD 201.93 7,785,300
USD 207.56 USD 209.24 USD 206.03 USD 206.37 24,803,900
USD 205.26 USD 208.26 USD 205.03 USD 207.49 7,545,900
USD 219.80 USD 221.21 USD 217.84 USD 220.14 6,950,600
USD 240.25 USD 240.74 USD 237.04 USD 238.64 9,378,500
USD 244.86 USD 247.25 USD 243.72 USD 245.17 7,698,200
USD 241.46 USD 244.40 USD 240.30 USD 242.04 7,710,200
USD 241.19 USD 242.68 USD 239.13 USD 240.45 7,617,600
USD 235.01 USD 242.19 USD 233.25 USD 240.10 10,318,700
USD 227.73 USD 231.03 USD 226.37 USD 227.79 7,179,800
USD 225.82 USD 230.80 USD 225.44 USD 230.42 7,464,500
USD 231.23 USD 231.50 USD 224.59 USD 225.33 13,897,700
USD 239.00 USD 239.50 USD 233.58 USD 235.66 7,732,000
USD 253.25 USD 254.20 USD 251.08 USD 253.98 6,516,500
USD 252.59 USD 255.66 USD 251.95 USD 253.04 10,167,700
USD 254.97 USD 257.75 USD 250.91 USD 254.41 8,136,300
USD 267.67 USD 271.73 USD 266.33 USD 271.11 7,838,200
USD 270.83 USD 271.91 USD 267.02 USD 271.19 6,033,600
USD 277.32 USD 278.89 USD 273.16 USD 278.43 5,940,300
USD 268.00 USD 270.87 USD 267.11 USD 270.22 6,568,800
USD 259.38 USD 259.38 USD 255.12 USD 256.03 10,940,400
USD 254.43 USD 255.56 USD 251.52 USD 253.79 8,678,979

Company Profile & Business Model Overview

Johnson & Johnson is a leading company in its sector with strong market presence and growth prospects.

Sustainability Strengths & Catalysts (Pros)

  • Diversified portfolio of businesses across healthcare, consumer, and pharmaceuticals
  • Strong track record of consistent and sustainable growth
  • Leading position in several key markets

Material Risks & Governance Concerns (Cons)

  • Relying on blockbuster drugs for a large portion of sales
  • Potential negative impact from US healthcare reform

Related ESG Peer Equities

Companies in Health Care evaluated across carbon intensity, social metrics, and board governance.

Explore Health Care Peers →

ESG & Sustainability Rating Breakdown

Synthesized multi-provider rating across Environmental, Social, and Corporate Governance dimensions.

Audited Methodology

MSCI ESG Rating

A

MSCI ESG industry rating benchmark.

Sustainalytics Risk Score

23.0

Medium

Data integrity and methodology

MSCI and Sustainalytics ratings are shown separately with their own observation dates; they are not blended into one score, and providers can disagree. Market quotes are delayed or last-close values, and every snapshot states its source and observation time. Read the full rating methodology.

FAQ

Frequently Asked Questions

Direct answers on sustainability scores, risk methodologies, and peer rankings.

What is Johnson & Johnson (JNJ)'s ESG rating and sustainability score?

Johnson & Johnson (JNJ) currently holds an MSCI ESG rating of A and a Sustainalytics ESG Risk Score of 23.0 (Audited Risk Band). Ratings evaluate environmental emissions, labor standards, board independence, and regulatory compliance.

Is Johnson & Johnson considered an ESG leader or laggard in Health Care?

Johnson & Johnson is classified as an Average ESG performer by MSCI with a A rating, indicating performance in line with mainstream sector peers with opportunities for further disclosure and risk management.

What are the main ESG risks and controversies for Johnson & Johnson?

Key material risks for Johnson & Johnson include: Relying on blockbuster drugs for a large portion of sales; Potential negative impact from US healthcare reform. Investors should evaluate whether corporate mitigation plans adequately address these vulnerabilities.

How does The Impact Investor evaluate ESG stock profiles?

The Impact Investor presents audited third-party ratings from MSCI and Sustainalytics alongside delayed market data and financial fundamentals. We do not blend ratings into proprietary black-box scores, and ratings are never modified by advertising or affiliate relationships.